Aceprometazine
From Self-sufficiency
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
File:Aceprometazine.svg | |
Systematic (IUPAC) name | |
---|---|
1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethanone | |
Clinical data | |
Pregnancy category |
|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal and fecal |
Identifiers | |
CAS Number | 13461-01-3 |
ATC code | none |
PubChem | CID 26035 |
DrugBank | DB01615 |
ChemSpider | 24249 |
Chemical data | |
Formula | C19H22N2OS |
Molar mass | 326.456 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
(verify) |
Aceprometazine (INN) is a phenothiazine derivative prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine.
35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from December 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Phenothiazines
- H1 receptor antagonists
- Ketones
- Nervous system drug stubs
- 2Fix